John F. Palma

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index2.1kcitations123works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(92), Colorectal Cancer Treatments and Studies(55), Genetic factors in colorectal cancer(44), Lung Cancer Treatments and Mutations(32), RNA modifications and cancer(9)

Publications122 total

Data from Advancing Global Health Equity in Oncology Clinical Trial Access
2024Open Access
Supplementary Figure 2 from Advancing Global Health Equity in Oncology Clinical Trial Access
2024Open Access
Supplementary Figure 1 from Advancing Global Health Equity in Oncology Clinical Trial Access
2024Open Access
Supplementary Table 1 from Advancing Global Health Equity in Oncology Clinical Trial Access
2024Open Access
Advancing Global Health Equity in Oncology Clinical Trial Access
Cancer Discovery·2024· 6 citedOpen Access
Figure S11 from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Data from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Figure S12 from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Figure S2 from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Data from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Table S1 from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Figure S4 from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Figure S12 from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Figure S3 from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Figure S8 from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Figure S11 from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Figure S8 from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Figure S5 from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Figure S6CD from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
Table S2 from Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Stephanie J. Yaung(16), Christine Ju(8), Yuqiu Jiang(6), Bernd Hinzmann(6), Hans-Peter Adams(5), Lijing Yao(5), Aarthi Balasubramanyam(5), Nalin Tikoo(5), Sidney Scudder(5), Corinna Woestmann(5), Herbert I. Hurwitz(4), Alan Nicholas(4), Nicolas Sommer(4), Johanna C. Bendell(4), Frederike Fuhlbrück(4), Guili Zhang(4), Partha Das(4), Xiaoju Max(4), Maximilian Schmid(4), Felix Herth(4)